Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Resource Type
Article
Authors
Straus, David J ; Długosz-Danecka, Monika ; Connors, Joseph M ; Alekseev, Sergey ; Illés, Árpád ; Picardi, Marco ; Lech-Maranda, Ewa ; Feldman, Tatyana ; Smolewski, Piotr ; Savage, Kerry J ; Bartlett, Nancy L ; Walewski, Jan ; Ramchandren, Radhakrishnan ; Zinzani, Pier Luigi ; Hutchings, Martin ; Munoz, Javier ; Lee, Hun Ju ; Kim, Won Seog ; Advani, Ranjana ; Ansell, Stephen M ; Younes, Anas ; Gallamini, Andrea ; Liu, Rachael ; Little, Meredith ; Fenton, Keenan ; Fanale, Michelle ; Radford, John
Source
In The Lancet Haematology June 2021 8(6):e410-e421
Subject
Primary Research Articles
Language
ISSN
2352-3026